| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.41 | 4e-08 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.35 | 9e-07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.31 | 1e-09 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.29 | 5e-09 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.26 | 5e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.25 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.24 | 7e-07 |